447 related articles for article (PubMed ID: 29457592)
1. PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.
Jafarizad A; Taghizadehgh-Alehjougi A; Eskandani M; Hatamzadeh M; Abbasian M; Mohammad-Rezaei R; Mohammadzadeh M; Toğar B; Jaymand M
Biomed Mater Eng; 2018; 29(2):177-190. PubMed ID: 29457592
[TBL] [Abstract][Full Text] [Related]
2. The Structure-Dependent Electric Release and Enhanced Oxidation of Drug in Graphene Oxide-Based Nanocarrier Loaded with Anticancer Herbal Drug Berberine.
Yu D; Ruan P; Meng Z; Zhou J
J Pharm Sci; 2015 Aug; 104(8):2489-500. PubMed ID: 26052932
[TBL] [Abstract][Full Text] [Related]
3. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
4. Fe3O4@mSiO2-FA-CuS-PEG nanocomposites for magnetic resonance imaging and targeted chemo-photothermal synergistic therapy of cancer cells.
Gao Z; Liu X; Deng G; Zhou F; Zhang L; Wang Q; Lu J
Dalton Trans; 2016 Sep; 45(34):13456-65. PubMed ID: 27493065
[TBL] [Abstract][Full Text] [Related]
5. Preparation of hollow core/shell Fe
Wang J; Fang J; Fang P; Li X; Wu S; Zhang W; Li S
J Biomater Sci Polym Ed; 2017 Mar; 28(4):337-349. PubMed ID: 27931160
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-grafted-poly(methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem.
Abbasian M; Roudi MM; Mahmoodzadeh F; Eskandani M; Jaymand M
Int J Biol Macromol; 2018 Oct; 118(Pt B):1871-1879. PubMed ID: 30017982
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
8. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
10. A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug.
Li J; Lyv Z; Li Y; Liu H; Wang J; Zhan W; Chen H; Chen H; Li X
Biomaterials; 2015 May; 51():12-21. PubMed ID: 25770993
[TBL] [Abstract][Full Text] [Related]
11. Fe3O4 magnetic nanoparticles/reduced graphene oxide nanosheets as a novel electrochemical and bioeletrochemical sensing platform.
Teymourian H; Salimi A; Khezrian S
Biosens Bioelectron; 2013 Nov; 49():1-8. PubMed ID: 23708810
[TBL] [Abstract][Full Text] [Related]
12. [Preparation and in vitro evaluation of doxorubicin-loaded magnetic iron oxide nanoparticles].
Shen S; Wu L; Wang CR; Qi XY; Ge YR; Jin Y
Yao Xue Xue Bao; 2013 Dec; 48(12):1844-9. PubMed ID: 24689244
[TBL] [Abstract][Full Text] [Related]
13. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
14. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Fe
Xu Y; Shan Y; Zhang Y; Yu B; Shen Y; Cong H
Nanotechnology; 2019 Oct; 30(42):425102. PubMed ID: 31261137
[TBL] [Abstract][Full Text] [Related]
16. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
17. PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate.
Abdollahi Z; Taheri-Kafrani A; Bahrani SA; Kajani AA
J Biotechnol; 2019 Jun; 298():88-97. PubMed ID: 30986517
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel biocompatible nanocomposite of graphene oxide and magnetic nanoparticles for drug delivery.
Aliabadi M; Shagholani H; Yunessnia Lehi A
Int J Biol Macromol; 2017 May; 98():287-291. PubMed ID: 28167110
[TBL] [Abstract][Full Text] [Related]
19. The synthesis of LA-Fe
Chen Y; Zhang F; Wang Q; Lin H; Tong R; An N; Qu F
Dalton Trans; 2018 Feb; 47(7):2435-2443. PubMed ID: 29379913
[TBL] [Abstract][Full Text] [Related]
20. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy.
Shi X; Gong H; Li Y; Wang C; Cheng L; Liu Z
Biomaterials; 2013 Jul; 34(20):4786-93. PubMed ID: 23557860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
